For the last few months, Serum Institute of India - the force behind the AstraZeneca COVID vaccine - has been working to launch CERVAVAC, the country's first indigenously developed HPV vaccine. It is slated to roll out between July and September this year. "This is going to be the first step towards ensuring a cervical cancer-free future in the country," Bisen tells mid-day.
Cervical cancer develops in the cervix, which is the lower and narrow end of the uterus that connects to the vagina. According to Dr Sewanti Limaye, director of oncology and precision medicine, Sir HN Reliance Foundation Hospital, the main cause of cervical cancer is the human papillomavirus, which is a sexually
transmitted infection.
Portal: Midday
With India's first HPV vaccine set to roll out in 2023, experts hope women finally have a fighting chance against cervical cancer
The Foundation lays significantemphasis on leveraging technology for developmental solutions.
RELIANCE FOUNDATION HOSPITAL Free Mobile App From
© 2024 Sir H. N. Reliance Foundation Hospital and Research Centre
Dear Guest,
We would be delighted to receive your feedback on our services.
Captcha * (case sensitive)
